NEW YORK (GenomeWeb News) – Health Discovery Corp. said today that it has taken a 15 percent equity stake in Smart Personalized Medicine, a prognostic test start-up founded by Richard Caruso, a former HDC board member and chairman and founder of Integra Life Sciences.
 
HDC said last week that Caruso had resigned his position as a board member to negotiate a license to use the firm’s support vector machine technology in developing a breast cancer prognostic test.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.